Nymox Pharmaceutical
NYMX
#7608
Rank
$18.25 M
Marketcap
Bahamas
Country
$0.20
Share price
0.00%
Change (1 day)
-47.37%
Change (1 year)
Categories
Nymox Pharmaceutical (NYMX) - Total liabilities
Total liabilities on the balance sheet as of June 2023 : $3.14 M
According to Nymox Pharmaceutical's latest financial reports the company's total liabilities are $3.14 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Nymox Pharmaceutical - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $2.1 M | 8.11% |
| 2021-12-31 | $1.94 M | -11.33% |
| 2020-12-31 | $2.19 M | 7.69% |
| 2019-12-31 | $2.04 M | 90.04% |
| 2018-12-31 | $1.07 M | -51.84% |
| 2017-12-31 | $2.23 M | -17.37% |
| 2016-12-31 | $2.69 M | -22.12% |
| 2015-12-31 | $3.46 M | -38.16% |
| 2014-12-31 | $5.6 M | -20.23% |
| 2013-12-31 | $7.02 M | -23.63% |
| 2012-12-31 | $9.19 M | -20.51% |
| 2011-12-31 | $11.57 M | -29.25% |
| 2010-12-31 | $16.35 M | 543.31% |
| 2009-12-31 | $2.54 M | 102.29% |
| 2008-12-31 | $1.25 M | -2.92% |
| 2007-12-31 | $1.29 M | -39.62% |
| 2006-12-31 | $2.14 M | -14.46% |
| 2005-12-31 | $2.5 M | 22.07% |
| 2004-12-31 | $2.05 M | 19.11% |
| 2003-12-31 | $1.72 M | 17.15% |
| 2002-12-31 | $1.47 M | 96.89% |
| 2001-12-31 | $0.74 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $125.10 B | 3,973,851.72% | 🇺🇸 USA |
 Pfizer PFE | $94.38 B | 2,998,025.79% | 🇺🇸 USA |
 Abbott Laboratories ABT | $36.56 B | 1,161,335.83% | 🇺🇸 USA |
 Eli Lilly LLY | $43.66 B | 1,386,961.63% | 🇺🇸 USA |
 Quest Diagnostics
DGX | $7.06 B | 224,201.14% | 🇺🇸 USA |